Simon Manyara Simon Manyara Simon Manhara works with our culture and sustainability team towards making a positive social impact and creating a sustainable future.
Christian Betz Christian Betz Christian Betz shares his experience leading the process engineering team at Boehringer Ingelheim site in Biberach, Germany.
Daniel Kiesenhofer Daniel Kiesenhofer Daniel Kiesenhofer talks about his role as Project Manager Quality Control at Boehringer Ingelheim in Vienna, Austria.
Anna Mistrioti Anna Mistrioti Anna Mistrioti speaks about working as a Quality Control Compliance Officer in Boehringer Ingelheim, in the Koropi Plant of Greece.
Corporate Compliance Program Corporate Compliance Program Our E&C Program conforms with the principles and recommendations published in guides from various Federal agencies and industry related organizations
Anna Mezentseva Anna Mezentseva Anna Mezentseva talks about being a discovery management trainee in Finance and Controlling.
Jan-Erik Schafer Jan-Erik Schafer Jan Erik, Senior Team Leader in the upstream pharmaceutical production talks about his motivating and fun career at Boehringer Ingelheim.
Ryan Henri Rickards Ryan Henri Rickards Ryan Henry Rickards, a senior finance manager for US Animal Health Commercial Controlling team, highlights his career at Boehringer Ingelheim.
What is pharmacovigilance & its role on patient safety What is pharmacovigilance & its role on patient safety
New GPP Consensus Statement Released New GPP Consensus Statement Released National Psoriasis Foundation Releases Consensus Statement on Management of Generalized Pustular Psoriasis (GPP)
Brigitte Fuhr Brigitte Fuhr Brigitte Fuhr, Head of Central Data Science, is working on a global program that will transform our ability to develop breakthrough treatments.
Benefits & Rewards Benefits & Rewards We invest in our people so they will stay and grow with us. We offer benefits such as rewards and development opportunities to help retain employees.
Cardiometabolic Diseases Cardiometabolic Diseases We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in CardioMetabolic diseases.